Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaurav Pathria

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Plos One|August 13, 2013
NVP-LDE225, a potent and selective SMOOTHENED antagonist reduces melanoma growth in vitro and in vivoAhmad Jalili, Kirsten D Mertz, Julia Romanov, et al.
NPJ Precision Oncology|July 20, 2024
Ancestry-associated co-alteration landscape of KRAS and EGFR-altered non-squamous NSCLCSaumya D Sisoudiya, Armande Ang Houle, Tharu Fernando, et al.
The EMBO Journal|September 14, 2018
Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survivalGaurav Pathria, David A Scott, Yongmei Feng, et al.
Nature Cell Biology|November 20, 2019
Translational reprogramming marks adaptation to asparagine restriction in cancerGaurav Pathria, Joo Sang Lee, Erez Hasnis, et al.
Nature Cell Biology|September 1, 2022
NRF2 mediates melanoma addiction to GCDH by modulating apoptotic signallingSachin Verma, David Crawford, Ali Khateb, et al.
Journal of the National Cancer Institute|September 22, 2012
Dual suppression of the cyclin-dependent kinase inhibitors CDKN2C and CDKN1A in human melanomaAhmad Jalili, Christine Wagner, Mikhail Pashenkov, et al.
Nature Communications|March 18, 2014
MTSS1 is a metastasis driver in a subset of human melanomasKirsten D Mertz, Gaurav Pathria, Christine Wagner, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Plos One|August 13, 2013
NVP-LDE225, a potent and selective SMOOTHENED antagonist reduces melanoma growth in vitro and in vivoAhmad Jalili, Kirsten D Mertz, Julia Romanov, et al.
NPJ Precision Oncology|July 20, 2024
Ancestry-associated co-alteration landscape of KRAS and EGFR-altered non-squamous NSCLCSaumya D Sisoudiya, Armande Ang Houle, Tharu Fernando, et al.
The EMBO Journal|September 14, 2018
Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survivalGaurav Pathria, David A Scott, Yongmei Feng, et al.
Nature Cell Biology|November 20, 2019
Translational reprogramming marks adaptation to asparagine restriction in cancerGaurav Pathria, Joo Sang Lee, Erez Hasnis, et al.
Nature Cell Biology|September 1, 2022
NRF2 mediates melanoma addiction to GCDH by modulating apoptotic signallingSachin Verma, David Crawford, Ali Khateb, et al.
Journal of the National Cancer Institute|September 22, 2012
Dual suppression of the cyclin-dependent kinase inhibitors CDKN2C and CDKN1A in human melanomaAhmad Jalili, Christine Wagner, Mikhail Pashenkov, et al.
Nature Communications|March 18, 2014
MTSS1 is a metastasis driver in a subset of human melanomasKirsten D Mertz, Gaurav Pathria, Christine Wagner, et al.
Pageof 2